Amplifon Appoints Renowned Audiology Researcher to Lead Innovation

Dr. Nicholas Reed to oversee research initiatives and drive advancements in hearing health at Amplifon

Apr. 2, 2026 at 10:25pm

Got story updates? Submit your updates here. ›

A highly detailed, translucent X-ray photograph revealing the delicate inner structures of the human ear, conveying a sense of scientific exploration and the pursuit of advancements in hearing care.Amplifon's investment in audiology research aims to uncover new insights into the complex mechanisms of hearing health.Minneapolis Today

Amplifon, the parent company of Miracle-Ear, has appointed Dr. Nicholas Reed, an internationally recognized audiology and public health researcher, to the newly created role of Vice President of Audiology Innovation and Research. In this position, Dr. Reed will oversee Amplifon's research initiatives and support the company's efforts to improve hearing health and patient outcomes.

Why it matters

Dr. Reed's appointment represents a significant investment by Amplifon in advancing the field of hearing care. His expertise in epidemiology and clinical audiology will help the company refine its protocols, make its services more innovative and personalized, and ultimately improve the quality of life for millions of people worldwide who struggle with hearing loss.

The details

Dr. Reed is known for his research that has highlighted the link between hearing loss and broader healthcare outcomes, including cognitive decline. He has previously held academic positions at NYU Grossman School of Medicine and Johns Hopkins University, and has more than 200 publications to his name. In his new role, he will be based at Amplifon Americas' headquarters in Minneapolis.

  • Dr. Reed was appointed to the newly created role of Vice President of Audiology Innovation and Research on April 2, 2026.

The players

Amplifon

The parent company of Miracle-Ear, a leading provider of hearing aids and hearing health services.

Dr. Nicholas Reed

An internationally recognized researcher in audiology and public health, with a focus on bridging the gap between clinical audiology and population health.

Enrico Vita

The chief executive officer of Amplifon.

Got photos? Submit your photos here. ›

What they’re saying

“We are honored to welcome Dr Nicholas Reed to our team. His reputation as a world-class researcher and his profound knowledge of hearing health make him the ideal person to lead our research initiatives in audiology.”

— Enrico Vita, Chief Executive Officer, Amplifon

“I have spent my career striving to ensure that research makes a tangible difference in people's lives. Joining Amplifon provides a unique global platform to scale that mission.”

— Dr. Nicholas Reed

What’s next

Dr. Reed will begin his new role at Amplifon's headquarters in Minneapolis, where he will oversee the company's research initiatives and work to drive advancements in hearing health.

The takeaway

Amplifon's appointment of Dr. Nicholas Reed, a renowned audiology and public health researcher, signals the company's commitment to innovation and improving the quality of life for those with hearing loss. By integrating Dr. Reed's expertise, Amplifon aims to refine its protocols, make its services more personalized, and ultimately deliver better outcomes for patients worldwide.